Suppr超能文献

在骨软骨修复模型中使用荧光纳米粒子对间充质干细胞进行体内示踪。

In vivo tracking of mesechymal stem cells using fluorescent nanoparticles in an osteochondral repair model.

机构信息

Department of Orthopaedics, Dongguk University Ilsan Hospital, Goyang, Korea.

出版信息

Mol Ther. 2012 Jul;20(7):1434-42. doi: 10.1038/mt.2012.60. Epub 2012 Apr 10.

Abstract

We devised and tested an in vivo system to monitor the migration of mesenchymal stem cells (MSCs) within the marrow cavity. In vitro studies confirmed that platelet-derived growth factor (PDGF)-AA had the most potent chemotactic effect of the tested factors, and possessed the greatest number of receptors in MSCs. MSCs were labeled with fluorescent nanoparticles and injected into the marrow cavity of nude rats through osteochondral defects created in the distal femur. The defects were sealed with HCF (heparin-conjugated fibrin) or PDGF-AA-loaded HCF. In the HCF-only group, the nanoparticle-labeled MSCs dispersed outside the marrow cavity within 3 days after injection. In the PDGF-AA-loaded HCF group, the labeled cells moved time-dependently for 14 days toward the osteochondral defect. HCF-PDGF in low dose (LD; 8.5 ng/µl) was more effective than HCF-PDGF in high dose (HD; 17 ng/µl) in recruiting the MSCs to the osteochondral defect. After 21 days, the defects treated with PDGF and transforming growth factor (TGF)-β1-loaded HCF showed excellent cartilage repair compared with other groups. Further studies confirmed that this in vivo osteochondral MSCs tracking system (IOMTS) worked for other chemoattractants (chemokine (C-C motif) ligand 2 (CCL2) and PDGF-BB). IOMTS can provide a useful tool to examine the effect of growth factors or chemokines on endogenous cartilage repair.

摘要

我们设计并测试了一种活体系统,以监测骨髓腔内间充质干细胞(MSCs)的迁移。体外研究证实血小板衍生生长因子(PDGF)-AA 是所有测试因子中最具趋化作用的,并且在 MSCs 中具有最多的受体。将荧光纳米颗粒标记的 MSCs 通过在股骨远端造成的骨软骨缺损注入骨髓腔。用肝素结合纤维蛋白(HCF)或负载 PDGF-AA 的 HCF 封闭缺损。在仅用 HCF 组中,在注射后 3 天内,纳米颗粒标记的 MSCs 分散在骨髓腔外。在负载 PDGF-AA 的 HCF 组中,标记的细胞在 14 天内时间依赖性地向骨软骨缺损处迁移。低剂量(LD;8.5 ng/µl)HCF-PDGF 比高剂量(HD;17 ng/µl)HCF-PDGF 更有效地将 MSCs 募集到骨软骨缺损处。21 天后,用 PDGF 和转化生长因子(TGF)-β1 负载的 HCF 治疗的缺损与其他组相比显示出优异的软骨修复。进一步的研究证实,这种活体骨软骨 MSCs 跟踪系统(IOMTS)适用于其他趋化因子(趋化因子(C-C 基序)配体 2(CCL2)和 PDGF-BB)。IOMTS 可以为研究生长因子或趋化因子对内源性软骨修复的影响提供有用的工具。

相似文献

引用本文的文献

6
Stem Cell Therapy: From Idea to Clinical Practice.干细胞治疗:从理念到临床实践。
Int J Mol Sci. 2022 Mar 5;23(5):2850. doi: 10.3390/ijms23052850.

本文引用的文献

6
Autologous engineering of cartilage.自体软骨工程。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3418-23. doi: 10.1073/pnas.0907774107. Epub 2010 Feb 4.
9

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验